IL2 and autoimmune disease: Interleukin-2 (IL-2), as a promising therapeutic agent for autoimmune diseases, is a cytokine that can selectively bind to the trimer IL-2 receptor (IL-2R) on regulatory T (Treg) cells and preferentially activate Treg cells.